cypusloidine
Life Science / Technology

An immunosuppressive drug developed by Tokugawa Pharmaceuticals. Able to completely suppress post-transplant rejection reaction, it led to the widespread adoption of organ transplantation. Unlike previous immunosuppressive drugs, it contained no side effects and only affected the transplanted cells, and was widely used until the development of transplant technology that prevents any rejection reaction, such as masked transplantation.